While generally well-tolerated, some individuals may experience mild gastrointestinal issues or rare allergic reactions
Although several theories with empirical support tackle the point, the causes of BIPN are multifactorial and not fully understood, it remains a potentially persistent adverse event that can lead to long-term objective neurological dysfunction (Li et al., 2020), thereby reducing the quality of life, weakening physical function, causing delays or dose reductions in chemotherapy, and in some cases even interrupting treatment, imposing a huge economic burden (Selvy et al., 2021)
RISE users say this helps them fall asleep without any sleep aids or supplements at all
Gradientdose 5-amino-1-methylquinolinium treatment further enables investigation of doseresponse relationships between NNMT inhibition, NAD+ levels, and metabolic efficiency, improving mechanistic understanding and supporting targetbased research for metabolic diseases
The integration of peptide therapy with conventional orthopedic rehabilitation is another area where coordinated approaches could accelerate timelines
